Skip to content
Pharmacology & Mechanisms

Cross-reactivity

The ability of a peptide designed for one receptor to bind to and activate related receptors. For example, Melanotan II activates multiple melanocortin receptor subtypes, producing both tanning and sexual arousal effects.

Frequently Asked Questions

What is Cross-reactivity?
The ability of a peptide designed for one receptor to bind to and activate related receptors. For example, Melanotan II activates multiple melanocortin receptor subtypes, producing both tanning and sexual arousal effects.
Why is Cross-reactivity important in peptide research?
Cross-reactivity is a key pharmacological concept that determines how peptides interact with the body. Understanding this term helps practitioners optimize dosing protocols, predict therapeutic outcomes, and minimize side effects.

Related Terms

Selectivity

The ability of a peptide to preferentially bind to one receptor subtype over others. Ipamorelin is considered a selective GH secretagogue because it stimulates GH release without significantly affecting cortisol or prolactin.

Receptor agonist

A molecule that binds to and activates a receptor, triggering a biological response. Semaglutide is a GLP-1 receptor agonist; ipamorelin is a ghrelin receptor agonist.

Melanocortin receptor

A family of five G protein-coupled receptors (MC1R–MC5R) involved in pigmentation, appetite regulation, sexual function, and inflammation. Targeted by PT-141 (MC3R/MC4R) and Melanotan II (multiple subtypes).

Related Peptide Profiles

Melanotan II

A synthetic analog of alpha-MSH that activates melanocortin receptors to stimulate melanogenesis (tanning) and sexual arousal.

PT-141

Bremelanotide, a melanocortin receptor agonist FDA-approved as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women.

← Back to full glossary